SEC Form D filing

ORLI Oncology Ventures II SPV, LLC

Biotech · Seed · Regulation D 506(b) · OH · Filed May 15, 2026

Offering amount: $368.8K
Exemption: Reg D 506(b)
Issuer state: OH
Filing date: May 15, 2026
Signature date: February 12, 2026
CIK: 0002126245

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Seed

Summary

Auto-generated

ORLI Oncology Ventures II SPV focuses on oncology; $368.75K offering suggests early-stage biotech fund.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.